As of 2024-12-14, the Relative Valuation of Medicenna Therapeutics Corp (MDNA.TO) is 1.78 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.77 CAD, the upside of Medicenna Therapeutics Corp based on Relative Valuation is 0.3%.
The range of the Relative Valuation is 1.78 - 1.78 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -5.2x - -5.2x | -5.2x |
| Fair Price | 1.78 - 1.78 | 1.78 |
| Upside | 0.3% - 0.3% | 0.3% |
| Date | P/E |
| 2024-12-09 | -5.51 |
| 2024-12-06 | -5.74 |
| 2024-12-05 | -5.83 |
| 2024-12-04 | -4.86 |
| 2024-12-03 | -5.04 |
| 2024-12-02 | -4.75 |
| 2024-11-29 | -5.04 |
| 2024-11-28 | -5.21 |
| 2024-11-27 | -5.21 |
| 2024-11-26 | -5.18 |
| 2024-11-25 | -4.89 |
| 2024-11-22 | -4.60 |
| 2024-11-21 | -4.36 |
| 2024-11-20 | -4.39 |
| 2024-11-19 | -4.75 |
| 2024-11-18 | -4.72 |
| 2024-11-15 | -4.25 |
| 2024-11-14 | -4.98 |
| 2024-11-13 | -4.95 |
| 2024-11-12 | -5.16 |
| 2024-11-11 | -6.06 |
| 2024-11-08 | -6.50 |
| 2024-11-07 | -7.24 |
| 2024-11-06 | -7.06 |
| 2024-11-05 | -7.03 |
| 2024-11-04 | -6.94 |
| 2024-11-01 | -7.35 |
| 2024-10-31 | -6.91 |
| 2024-10-30 | -6.77 |
| 2024-10-29 | -6.50 |
| 2024-10-28 | -6.85 |
| 2024-10-25 | -6.88 |
| 2024-10-24 | -6.50 |
| 2024-10-23 | -6.18 |
| 2024-10-22 | -6.30 |
| 2024-10-21 | -6.50 |
| 2024-10-18 | -6.68 |
| 2024-10-17 | -6.91 |
| 2024-10-16 | -6.71 |
| 2024-10-15 | -7.00 |
| 2024-10-11 | -6.53 |
| 2024-10-10 | -6.47 |
| 2024-10-09 | -6.30 |
| 2024-10-08 | -6.59 |
| 2024-10-07 | -6.12 |
| 2024-10-04 | -6.44 |
| 2024-10-03 | -6.01 |
| 2024-10-02 | -6.15 |
| 2024-10-01 | -5.65 |
| 2024-09-30 | -5.54 |